ArticleVeterinary world2025
Global seroprevalence and distribution of Getah virus in domestic and wild animals: A systematic review and meta-analysis.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Utilization of meat juice from market-purchased pork for serological surveillance of mosquito-borne arboviruses.The Journal of veterinary medical science · 2026Article
- Development and validation of an E2 based indirect ELISA for serological detection of porcine Getah virus.Veterinary research communications · 2026Article
- Isolation and Molecular Characterization of Emerging Getah Virus Genotype III Variant Strains from Swine in Southeastern China (2024-2025).International journal of molecular sciences · 2026Article
- Can a mosquito-borne virus become a cancer therapy? rethinking Getah virus through the lens of oncolytic virotherapy.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Getah virus (GETV), a mosquito-borne alphavirus of veterinary importance, has caused periodic outbreaks in domestic animals, especially in Asia. Although several studies have reported evidence of infection in animals, the overall global seroprevalence remains unclear. This study aimed to comprehensively synthesize available evidence on the worldwide seroprevalence of GETV in domestic and wild animals and identify epidemiological patterns across host types, regions, and detection methods. Materials and Methods: A systematic search of PubMed, Scopus, ScienceDirect, and Web of Science was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, without temporal or regional restrictions. Eligible studies reporting serological detection of GETV antibodies in animal populations were included. Data were extracted and analyzed using a DerSimonian-Laird random-effects model, with subgroup analyses stratified by country, host category, sampling period, and diagnostic method. Heterogeneity was quantified using I Results: Fifteen studies (n = 10,211 animals) met the inclusion criteria. The pooled global seroprevalence of GETV was 33.3% (95% confidence interval: 24.2-43.9; I Conclusion: This meta-analysis demonstrates that GETV is endemic among Asian animal populations, particularly domestic livestock, indicating substantial virus circulation across species. The findings underscore the need for enhanced veterinary surveillance, standardized serological testing, and One Health-oriented monitoring frameworks to detect and mitigate GETV transmission risks. The absence of data from Africa, Europe, and the Americas highlights an urgent need for geographically expanded research to better understand the virus's global distribution and zoonotic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.